Stock listing

Sprint Bioscience Ab

Selected listing: SPRINT · OMXSTO · SEK · SE

Sprint Bioscience Ab (Stockholm:SPRINT), Health Technology. Latest release Jul 23, 2026: Sprint Bioscience announces agreement with Lilly TuneLab…

SPRINT:OMXSTOSEKSEUpdated October 3, 2026

Ticker: Stockholm:SPRINT
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Stockholm
Currency: SEK

About Sprint Bioscience Ab

Sprint Bioscience AB is a public company listed on the Swedish market under the ticker SPRINT. Sprint Bioscience focuses on developing innovative therapies for cancer treatment.

Latest news from Sprint Bioscience Ab

Sprint Bioscience announces agreement with Lilly TuneLab to accelerate drug development

July 23, 2026

Sprint Bioscience (publ) announces that Aktiespararna initiates commissioned research coverage of the company

June 4, 2026

Sprint Bioscience completes strategic STK25 evaluation; continued focus on the primary indication

April 16, 2026

Sprint Bioscience appoints Jenni Björnulfson as CFO

April 1, 2026

Sprint Bioscience sells the TREX1 program to Gilead

November 24, 2025

All Sprint Bioscience Ab news →

Research Sprint Bioscience Ab

Sprint Bioscience Ab company profile

View the public company page for Sprint Bioscience Ab on 6ix.

Sprint Bioscience Ab news

Read company news and market updates connected to Sprint Bioscience Ab.

Sprint Bioscience Ab investor events

Find investor webinars, events, and replay context for Sprint Bioscience Ab.